5 Best Quality Stocks To Own For 2014

Bank of America (NYSE: BAC  ) had a pretty decent week, relatively speaking. It was boosted earlier in the week when news of a settlement with MBIA reached the markets, and even some threatened legal action by the state of New York didn’t affect it all that much. Even Friday morning, with Citigroup and JPMorgan Chase relatively flat, Bank of America remains slightly higher.

Meeting resistance
It was a little less than two weeks ago that my colleague John Grgurich wondered if Bank of America would remain closer to $10 than not. Obviously, it seems to have pushed past this threshold, but it seems to be meeting resistance around $13 a share. Granted, it is only in the past couple of days that the stock has traded above this level, but there has been numerous times over the past few months where it has approached, but not exceeded, this price:

BAC data by YCharts.

5 Best Quality Stocks To Own For 2014: VizStar Inc (VIZS)

VizStar, Inc. (VizStar), formerly Easy CD Yearbook, Inc., incorporated on June 27, 2006, is a development-stage company. The Company focuses to market software, which enables schools, clubs and organizations to produce their own multimedia yearbook. On June 11, 2010, Celestial Jets, Inc. (Celestial Jets) merged with the Company. Celestial Jets merged (the merger) with and into the Company’s wholly owned subsidiary, Celestial Acquisition Corp. Upon the merger, the name of Celestial Acquisition Corp. became Celestial Jets, Inc. In December 2012, the Company acquired Kimberly Parry Corporation.

A multimedia yearbook is a compact disc (CD)/ digital versatile disc (DVD), which contains video, photos, audio and text that is personal computer (PC) and Mac compatible. As of May 31, 2010, the Company had no revenues.

The Company competes with Yeardisk, Digital Journey LLC and Interactive Software Designs.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap stocks VizStar Inc (OTCMKTS: VIZS), SOHM Inc (OTCMKTS: SHMN) and American Soil Technologies, Inc (OTCMKTS: SOYL) have been getting some attention in various investment newsletters with two out of three of these stocks being the subject of paid promotions. However, there is nothing wrong with some paid for attention so long as everything is properly disclosed, but its going to be up to investors and traders alike to ultimately decide whether any of these stocks have what it takes to be the next hot stock. With that in mind, here is a quick reality check about all three small cap stocks:

5 Best Quality Stocks To Own For 2014: Vocus Inc.(VOCS)

Vocus, Inc. provides cloud marketing software that enables businesses attract, engage, and retain customers in the United States, Europe, Asia, and Morocco. It offers a suite of software for social media marketing, search marketing, email marketing, and publicity. The company?s cloud marketing solutions include search marketing and news distribution solution that helps customers increase their online visibility and organic search engine rankings with press releases; and email marketing solution, which provides a method of keeping in touch with prospects and customers by using professional looking emails to send newsletters, special offers, and other useful content. Its cloud marketing solutions also comprise social media software solution that helps customers run social marketing campaigns, as well as monitor and analyze conversations across multiple social networks and other online Websites; and publicity solution, which offers media database, news monitoring, and analyt ics and publicity opportunities that help companies increase their media exposure, manage relationships with reporters, and monitor and analyze trends unfolding in the media. The company also provides professional services that consist of data migration, custom development, and training. Vocus, Inc. sells its products to the financial and insurance, technology, healthcare and pharmaceutical, and retail and consumer products industries, as well as government agencies, not-for-profit organizations, and educational institutions through its direct sales channels, indirect sales channels, and the Internet. Vocus, Inc. was founded in 1988 and is headquartered in Beltsville, Maryland.

Advisors’ Opinion:

  • [By Seth Jayson]

    Vocus (Nasdaq: VOCS  ) reported earnings on April 23. Here are the numbers you need to know.

    The 10-second takeaway
    For the quarter ended March 31 (Q1), Vocus met expectations on revenues and missed estimates on earnings per share.

  • [By Rich Smith]

    In a separate statement, the company announced a small change in management, bringing in ex-Vocus (NASDAQ: VOCS  ) Chief Operating Officer William R. Wagner to become its own COO. In an SEC filing, LogMeIn noted that it will pay Wagner $400,000 in annual base salary, plus:

  • [By Alex Planes]

    What: Shares of Vocus (NASDAQ: VOCS  ) have plunged 15% today after the company’s forward guidance failed to impress the Street.

    So what: Vocus reported its earnings last evening, and both the $46.6 million top line and the $0.01 earnings per share result were better than Wall Street’s consensus, which sought a $45.3 million revenue number and a $0.02 loss per share. However, third-quarter guidance of $46.5 million to $46.8 million on the top line is below the $47 million consensus, and a $0.03 to $0.04 EPS result is roughly in line with the $0.03 consensus. Additionally, the full fiscal year’s guidance of $188 million to $189 million is roughly in line with the $188.2 million consensus.

  • [By The GeoTeam]

    Our recent 2013 articles on SaaS companies Selectica (SLTC), E2open (EOPN), Responsys (MKTG), Vocus (VOCS), and ExactTarget (ET) highlighted such opportunities. The average return since the inception of our coverage currently stands at around 34% (55% at their highs).

5 Best Quality Stocks To Own For 2014: MEDIWARE Information Systems Inc.(MEDW)

Mediware Information Systems, Inc., together with its subsidiaries, engages in the design, development, and marketing of software solutions targeting specific processes within healthcare institutions. The company offers software systems consisting of company’s proprietary application software, and third-party licensed software and hardware. It licenses, implements, and supports clinical and performance management, blood donor, and blood and biologic management products in the United States; and medication management solutions in the United States, the United Kingdom, Ireland, and South Africa. The company?s blood and biologics management solutions include HCLL Transfusion and HCLL Donor, which address blood donor recruitment, blood processing, and transfusion activities for hospitals and medical centers; BloodSafe suite of hardware and software that enable healthcare facilities to store, monitor, distribute, and track blood products; LifeTrak software for blood centers; a nd BiologiCare, a bone, tissue, and cellular product tracking software. Its medication management products comprise WORx, a pharmacy information system to manage inpatient and outpatient pharmacy operations; MediCOE, a physician order entry module; MediMAR, a nurse point-of-care administration and bedside documentation module; MediREC, which assists in achieving compliance with a Joint Commission mandate; and pharmacy management and electronic prescribing systems. The company?s performance management products include InSight software that tracks performance metrics to assist healthcare managers to manage performance. It also provides software installation and maintenance services, as well as billing and collection services to home infusion and home/durable medical equipment markets. The company markets its products primarily through its direct sales force. Mediware Information Systems, Inc. was founded in 1970 and is headquartered in Lenexa, Kansas.

Advisors’ Opinion:

  • [By CRWE]

    Mediware Information Systems, Inc. (Nasdaq:MEDW) plans to acquire the assets of Indianapolis-based Strategic Healthcare Group LLC (SHG), a leading provider of blood management consulting, education and informatics solutions.

5 Best Quality Stocks To Own For 2014: Cyberonics Inc (CYBX)

Cyberonics, Inc. (Cyberonics), incorporated in 1987, is a medical device company. The Company is engaged in the design, development, sales and marketing of implantable medical devices that provide a neuromodulation therapy, vagus nerve stimulation therapy (VNS Therapy), for the treatment of refractory epilepsy and treatment-resistant depression (TRD) and other device solutions for the management of epilepsy.VNS Therapy System includes an implantable pulse generator to provide stimulation to the vagus nerve; a lead that connects the generator to the vagus nerve; equipment to assist with implantation surgery; equipment to assist with setting the stimulation parameters for each patient; instruction manuals, and magnets to suspend or induce stimulation manually. The VNS Therapy pulse generator and lead are surgically implanted into patients generally during an outpatient procedure. The VNS Therapy System consists of a pulse generator, a bipolar lead, a programming wand and sof tware and a tunneling tool.

The United States Food and Drug Administration (FDA) approved the Company’s VNS Therapy System in July 1997 for use as an adjunctive therapy in epilepsy patients over 12 years of age for reducing the frequency of partial onset seizures that are refractory or resistant to antiepileptic drugs. Regulatory bodies in Canada, the European Economic Area, certain countries in Eastern Europe, Russia, South America, Africa, Australia and certain countries in Asia, including Japan, China and Taiwan, have approved the VNS Therapy System for the treatment of epilepsy, many without age restrictions or seizure-type limitations. In July 2005, the FDA approved the Company’s VNS Therapy System for the adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a depressive episode and have not had an adequate response to four or more adequate anti-depressant treatments. Regulatory bodies in the European Economic Area, Canada and Israel have approv! ed the Company’s VNS Therapy System for the treatment of chronic or recurrent depression in patients who are in a treatment-resistant or treatment-intolerant depressive episode without age restrictions.

In February 2011, the Company announced FDA approval of its fifth generation generator, the AspireHC generator. In August 2011, the Company announced that the Company discovered a hardware-related design issue with the AspireHC Model 105 and AspireSR (Seizure Response) Model 106 generators. In December 2011, the FDA approved the Company’s re-designed AspireHC generator, and the Company resumed its limited commercial release of the generator in the United States.

Pulse Generator

The pulse generator is an implantable, programmable signal generator designed to be coupled with the bipolar lead to deliver mild electrical pulses to the vagus nerve. The pulse generator is a battery-powered device. Before or upon depletion of the battery, the pu lse generator may be removed and a new generator implanted in a short, outpatient procedure. The Model 102 (Pulse), Model 102R (Pulse Duo ), Model 103 (Demipulse), Model 104 (Demipulse Duo) and Model 105 (AspireHC), are the VNS Therapy pulse generators the Company offers and are similar in design and manufactures to a cardiac pacemaker.

Bipolar Lead

The bipolar lead conducts the electrical signal from the pulse generator to the vagus nerve. The lead incorporates electrodes, which are self-sizing, minimizing mechanical trauma to the nerve. The lead’s two electrodes and anchor tether wrap around the vagus nerve, and the connector end is tunneled subcutaneously to the upper chest area, where it attaches to the pulse generator. The Company offers three lead models in the United States. The leads are available in two inner spiral diameter sizes to ensure optimal electrode placement on different-sized nerves.

Programming Wand and Software

The Company’s programming wand and software are us! ed to int! errogate the implanted pulse generator and to transmit programming information from a handheld computer to the pulse generator via an inductive coupling. Programming capabilities include modification of the pulse generator’s programmable parameters (pulse width, amplitude and frequency and stimulation ON and OFF intervals) and storage and retrieval of telemetry data.

Tunneling Tool

The tunneling tool is a single use, sterile, disposable surgical tool designed to be used during surgical placement of the bipolar lead. The tool is used for subcutaneous tunneling of the lead between the nerve site in the neck and the pulse generator site in the upper chest area.

Accessory Pack

The accessory pack includes two resistor assemblies used to test the function of the device prior to implantation, the bipolar lead tie-downs and one hex screwdriver. The patient kit includes two magnets, one watch-style and one pager-style.

The Company competes with Medtronic, Inc., NeuroSigma Inc. and CerboMed GmbH.

Advisors’ Opinion:

  • [By Benjamin Shepherd]

    The rise of public health services, improvements in sanitation and access to clean drinking water have led to a huge improvement in human life expectancy, which has jumped from only about 30 years five centuries ago to more than 75 years in most industrialized countries today.

    Advances in medical science have also played a major role, such as the development of antibiotics to treat once deadly infections, surgical interventions to correct once fatal injuries and medications to treat chronic conditions.

    We have yet to reach the limit of human ingenuity and today the trend is towards harnessing technology to break the reliance on long-term medication usage to treat chronic conditions. One area where huge strides are being made in that direction is the treatment of epilepsy.

    Epilepsy is the fourth most common neurological disease in the world, affecting more than 9 million people in developed countries alone, and epileptics have a mortality rate more than 25 times higher than the general population. The costs associated with dealing with the disease run in excess of $13.5 billion in the US alone.

    The disease is typically treated using a drug regime that includes several pills a day, including anti-convulsants and sedatives which can have unpleasant side effects. Drug therapy is typically successful in controlling seizures in about 70 percent of patients, but about a third of those who don’t respond to medication find themselves undergoing surgery to essentially remove the area of the brain triggering the seizures.

    Cyberonics (NSDQ: CYBX) is making headway into an alternative treatment for the disease, called vagus nerve stimulation (VNS) therapy, which can reduce the number or even eliminate the need for the drugs epileptics depend upon and requires only minor surgery.

    During an outpatient procedure conducted under general anesthesia, two small incisions are made, one in the upper chest area and the ot her in the neck. At t

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Cyberonics (Nasdaq: CYBX  ) , whose recent revenue and earnings are plotted below.

5 Best Quality Stocks To Own For 2014: McKesson Corp (MCK)

McKesson Corporation, incorporated on July 7, 1994, delivers pharmaceuticals, medical supplies and healthcare information technologies. The Company operates in two segments: McKesson Distribution Solutions segment and McKesson Technology Solutions segment. The McKesson Distribution Solutions segment distributes drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. The McKesson Technology Solutions segment delivers enterprise clinical, patient care, financial, supply chain, strategic management software solutions, pharmacy automation for hospitals, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. In February 2013, the Company completed acquisition of Pss World Medical Inc. In February 2014, McKesson Corporation announced that its ownership in Celesio AG exceeds 75% interest.

Distribution Solutions

McKesson Dist ribution Solutions consists of the businesses, which include United States Pharmaceutical Distribution, McKesson Canada, Medical-Surgical Distribution, McKesson Specialty Health and McKesson Pharmacy Systems and Automation. United States Pharmaceutical Distribution business supplies pharmaceuticals and/or other healthcare-related products to customers in three primary customer channels: retail national accounts (including national and regional chains, food/drug combinations, mail order pharmacies and mass merchandisers); independent retail pharmacies, and institutional healthcare providers (including hospitals, health systems, integrated delivery networks, clinics and alternate site providers). This business also provides solutions and services to pharmaceutical manufacturers. This business sources materials and products from a range of different suppliers, including the production of certain generic pharmaceutical drugs through a contract-manufacturing program.

The Company’s United States pharmaceutical distribution b! usiness operates and serves thousands of customer locations through a network of 28 distribution centers, as well as a primary redistribution center, a strategic redistribution center and two repackaging facilities, serving all 50 states and Puerto Rico. It invests in technology and other systems at all of its distribution centers to enhance safety and reliability and provide the product availability for its customers. In addition, it offers Mobile ManagerSM, which integrates portable handheld technology with Acumax Plus to give customers complete ordering and inventory control. The Company also offers McKesson ConnectSM, an Internet-based ordering system that provides item lookup and real-time inventory availability, as well as ordering, purchasing, third-party reconciliation and account management functionality. Together, these features help ensure customers have the right products at the right time for their facilities and patients.

The offerings of the McKes son United States Pharmaceutical Distribution business by customer group can be categorized as retail national accounts, independent retail pharmacies and institutional healthcare providers. Retail National Accounts is a business solutions that help national account customers increase revenues and profitability. Solutions include Central Fill, Redistribution Centers, EnterpriseRx, RxPak, Inventory Management, McKesson OneStop Generics and ExpressRx Track.

Independent Retail Pharmacies is a solutions for managed care contracting, branding and advertising, merchandising, purchasing, operational efficiency and automation that help independent pharmacists focus on patient care while improving profitability. Solutions include Health Mart, AccessHealth, McKesson Reimbursement Advantage, McKesson OneStop Generics, EnterpriseRx, Sunmark, FrontEdge and McKesson Sponsored Clinical Services (SCS) Network. Institutional Healthcare Providers is a electronic ordering/purchas ing and supply chain management systems that help customers ! improve f! inancial performance, increase operational efficiencies and deliver better patient care. Solutions include McKesson Pharmacy Optimization, Fulfill-Rx, Asset Management, SKY Packaging, McKesson Plasma and BioLogics, McKesson OneStop Generics and McKesson 340B Solution Suite and Macro Helix.

Medical-Surgical Distribution business provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers including physicians’ offices, surgery centers, extended care facilities, homecare and occupational health sites through a network of distribution centers within the United States. This business is a provider of supplies to the full range of alternate-site healthcare facilities, including physicians’ offices, clinics and surgery centers (primary care), long-term care, occupational health facilities and homecare sites (extended care). McKesson Specialty Health business provides solutions for oncology and other specialty practices operating in communities across the country, as well as for pharmaceutical and biotech suppliers who manufacture specialty drugs and vaccines.

The Company provides direct-to-physician specialty distribution services, ensuring supply chain safety and delivery of specialty drugs in manufacturer recommended conditions. Third party logistics (3PL), are offered primarily for vaccine distribution, including its exclusive distributor relationship in the Centers for Disease Control and Prevention’s (CDC) Vaccines for Children program. The Company also offer its industry Lynx integrated technologies, the iKnowMed Electronic Health Record, and clinical and practice management tools, all of which help community practices improve inventory management, practice workflow and reimbursement processes, as well as deliver business efficiencies and clinical-decision support. McKesson Specialty Health works with manufacturers across all phases of the product development and commer cialization lifecycle, including clinical research, to optim! ize deliv! ery of complex medication to patients.

McKesson Pharmacy Systems and Automation business supplies integrated pharmacy management systems, automated dispensing systems and related services to retail, outpatient, central fill, specialty and mail order pharmacies. Its primary approach is to provide the customer with a pharmacy management system that suits the particular needs of their business operation.

Technology Solutions

The Company’s Technology Solutions segment provides a portfolio of software, automation, support and services to help healthcare organizations. This segment also includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. Technology Solutions markets its products and services to integrated delivery networks, hospitals, physician practices, home healthcare providers, retail pharmacies and payers. The product portfolio for the Technology Solutions segment is designed to a ddress a range of healthcare clinical and business performance needs ranging from medication safety and information access to revenue cycle management, resource utilization and physician adoption of electronic health records (EHR). Technology Solutions consists of businesses, which include McKesson Health Solutions, Enterprise Medical Imaging and Ancillary Solutions, RelayHealth, Revenue Management Solutions, Enterprise Information Solutions, Hospital Automation and International Technology.

McKesson Health Solutions services and software products is designed to manage the cost and quality of care for payers, providers, hospitals and government organizations. Solution sets include InterQual Criteria for clinical decision support and utilization management; Claims payment solutions to facilitate accurate and efficient medical claim payments; Business intelligence tools for measuring, reporting and improving clinical and financial performance; Network management t ools to enable health plans to transform the performance of ! their net! works, and RelayHealth financial solutions to facilitate communication between healthcare providers and patient aggregate data for claims management and trend analysis, and optimize revenue cycle management processes.

The Company offers medical imaging and information management systems for healthcare enterprises, including a picture archiving communications system, a radiology information system and a cardiovascular information system. The Company’s enterprise approach to medical imaging enables organizations to take advantage of specialty-specific workstations, while building an integrated image repository that manages all of the images and information captured throughout the care continuum. Through its vendor-neutral RelayHealth and its intelligent network, the Company provides health information exchange solutions that streamline clinical and administrative communication between patients, providers, payers, pharmacies, manufacturers, government and financi al institutions. RelayHealth helps to accelerate the delivery of care and improve financial performance through online consultation of physicians by patients, electronic prescribing by physicians, and point-of-service resolution of pharmacy claims by payers.

The Company help providers focus their resources on delivering healthcare while managing their revenue cycle operations and information technology through a suite of managed services. Services include full and partial revenue cycle outsourcing, remote hosting and business office administration. The Company also provides a solution for physician practices of all sizes, whether they are independent or employed, that includes software, revenue cycle outsourcing and connectivity services. Software solutions include practice management and EHR software for physicians of every size and specialty. The Company provides clinical and financial information systems for hospitals and health systems of all sizes. These sy stems are designed to improve the safety and quality of pati! ent care ! and improve clinical, financial and operational performance. Clinical functionality includes a data repository, care planning, physician order entry and documentation, nursing documentation with bar-coded medication administration, pharmacy, surgical management, emergency department and ambulatory EHR systems, and a Web-based physician portal. Automation solutions include technologies that help hospitals re-engineer and improve their medication use processes. The Company provides patient administration systems and clinical products to health and social care systems of all sizes in the United Kingdom and other European countries.

Advisors’ Opinion:

  • [By John Udovich]

    In the wake of the Obamacare fiasco, small cap healthcare information systems stock Computer Programs & Systems, Inc (NASDAQ: CPSI) has put in a good performance, meaning its worth taking a closer look at the stock along with the performance of large cap players like Cerner Corporation (NASDAQ: CERN) and McKesson Corporation (NYSE: MCK) and small cap Quality Systems, Inc (NASDAQ: QSII).

  • [By Stephen Quickel]

    By far, the largest is McKesson Corp. (MCK), a San Francisco giant, with revenues nearing $130 billion, from medical supplies and medical technologies.

  • [By John Kell]

    McKesson Corp.(MCK) said it received the necessary support to acquire German rival Celesio AG(CLS1.XE), about a week after saying it hadn’t received the requisite 75% backing from investors. Shares redged up 3% to $177.50 premarket.